Le PDG de Mirion Technologies, Thomas Logan, et l'initiée de Mirum Pharmaceuticals, Pamela Vig, ont vendu des actions pour 81 675 $ et 1,039 millions de dollars, respectivement. Mirion Technologies CEO Thomas Logan and Mirum Pharmaceuticals insider Pamela Vig sold shares for $81,675 and $1.039 million, respectively.

Le PDG de Mirion Technologies, Thomas Logan, a vendu 7 500 actions pour 81 675 $, lui laissant 1,54 million d'actions ; Pamela Vig, initiée de Mirum Pharmaceuticals, a vendu 30 559 actions pour 1,039 million de dollars, lui laissant 27 406 actions. Mirion Technologies CEO Thomas Logan has sold 7,500 shares of stock for $81,675, leaving him with 1.54 million shares; Mirum Pharmaceuticals insider Pamela Vig sold 30,559 shares for $1.039 million, leaving her with 27,406 shares. Le cours de l'action de Mirion Technologies varie de 6,70 $ à 11,49 $, tandis que celui de Mirum Pharmaceuticals varie de 23,14 $ à 35,56 $. Mirion Technologies' stock price ranges from $6.70 to $11.49, while Mirum Pharmaceuticals' stock has a range of $23.14 to $35.56.

Articles

Modern Readers

Markets Daily

WKRB 13

Daily Political

Modern Readers

-- afficher moins --

Articles connexes